This inventor holds 1 USPTO granted patent. Top assignee: Terremoto Biosciences, Inc.. Active years: 2026.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
Years Active: 2026
Title: Brian P Bestvater: Innovator in Pharmaceutical Modulation
Introduction
Brian P Bestvater is an accomplished inventor based in South San Francisco, CA. He has made significant contributions to the field of pharmaceutical sciences, particularly in the modulation of AKT1, a crucial protein involved in various cellular processes.
Latest Patents
Brian holds a patent for "Non-covalent modifiers of AKT1 and uses thereof." This patent includes non-covalent modifiers of AKT1 of various formulas and outlines methods for modulating wild-type AKT1 using these compounds. The implications of this work are substantial, as it opens new avenues for therapeutic interventions.
Career Highlights
Brian is currently associated with Terremoto Biosciences, Inc., where he continues to innovate in the pharmaceutical sector. His work focuses on developing novel compounds that can effectively modulate biological pathways, contributing to advancements in medical treatments.
Collaborations
Brian collaborates with Hang Chu, leveraging their combined expertise to drive forward innovative solutions in their field.
Conclusion
Brian P Bestvater exemplifies the spirit of innovation in pharmaceutical sciences, with his work on AKT1 modulation paving the way for future advancements in treatment methodologies.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile